• Citoxlab Acquires Solvo Biotechnology contractpharma
    March 13, 2018
    Citoxlab Group, a non-clinical CRO, has entered into a definitive agreement to acquire Solvo Biotechnology, a CRO specializing in drug transporter studies and the assessment of Drug-Drug Interactions (DDI).
PharmaSources Customer Service